LOPERAMIDE vs LORLATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LOPERAMIDE vs LORLATINIB: Safety Overview
| Metric | LOPERAMIDE | LORLATINIB |
|---|---|---|
| Total FAERS Reports | 18,011 | 5,508 |
| Deaths Reported | 1,551 | 1,542 |
| Death Rate | 8.6% | 28.0% |
| Hospitalizations | 4,298 | 1,232 |
| Average Patient Age | 58.9 yrs | 56.5 yrs |
| % Female Patients | 64.3% | 54.0% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | Nov 2, 2018 |
| Manufacturer | Chain Drug Consortium | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |